EyePoint Pharmaceuticals Inc (EYPT)
10.71
-0.04
(-0.37%)
USD |
NASDAQ |
May 31, 16:00
10.70
-0.01
(-0.09%)
After-Hours: 20:00
EyePoint Pharmaceuticals Total Return Level: 10.71 for May 31, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 31, 2024 | 10.71 |
May 30, 2024 | 10.75 |
May 29, 2024 | 10.96 |
May 28, 2024 | 11.13 |
May 24, 2024 | 11.16 |
May 23, 2024 | 11.11 |
May 22, 2024 | 11.47 |
May 21, 2024 | 11.59 |
May 20, 2024 | 12.14 |
May 17, 2024 | 11.84 |
May 16, 2024 | 12.52 |
May 15, 2024 | 12.94 |
May 14, 2024 | 12.45 |
May 13, 2024 | 12.22 |
May 10, 2024 | 12.09 |
May 09, 2024 | 12.67 |
May 08, 2024 | 11.56 |
May 07, 2024 | 11.87 |
May 06, 2024 | 11.20 |
May 03, 2024 | 19.74 |
May 02, 2024 | 19.94 |
May 01, 2024 | 18.04 |
April 30, 2024 | 17.60 |
April 29, 2024 | 17.63 |
April 26, 2024 | 16.75 |
Date | Value |
---|---|
April 25, 2024 | 16.16 |
April 24, 2024 | 16.47 |
April 23, 2024 | 17.57 |
April 22, 2024 | 16.95 |
April 19, 2024 | 17.65 |
April 18, 2024 | 17.50 |
April 17, 2024 | 20.94 |
April 16, 2024 | 21.84 |
April 15, 2024 | 21.28 |
April 12, 2024 | 22.45 |
April 11, 2024 | 22.89 |
April 10, 2024 | 21.71 |
April 09, 2024 | 21.53 |
April 08, 2024 | 20.73 |
April 05, 2024 | 20.28 |
April 04, 2024 | 20.15 |
April 03, 2024 | 20.75 |
April 02, 2024 | 20.28 |
April 01, 2024 | 20.27 |
March 28, 2024 | 20.67 |
March 27, 2024 | 20.81 |
March 26, 2024 | 20.63 |
March 25, 2024 | 21.69 |
March 22, 2024 | 22.26 |
March 21, 2024 | 23.42 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.28
Minimum
Mar 24 2023
29.71
Maximum
Feb 12 2024
10.94
Average
9.89
Median
Jan 21 2021
Total Return Level Benchmarks
Nanoviricides Inc | 2.40 |
Bio-Path Holdings Inc | 2.10 |
GlycoMimetics Inc | 0.2716 |
Ocular Therapeutix Inc | 5.70 |
Aileron Therapeutics Inc | 3.20 |